Information Provided By:
Fly News Breaks for January 6, 2020
Jan 6, 2020 | 07:05 EDT
H.C. Wainwright analyst Oren Livnat lowered his price target for Novan to $1.50 from $6.00 after the SB206 Phase 3 trials missed the primary endpoint. The analyst maintains a Buy rating on the shares.
News For NOVN From the Last 2 Days
There are no results for your query NOVN